KHK7580
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Secondary Hyperparathyroidism
Conditions
Secondary Hyperparathyroidism
Trial Timeline
Sep 29, 2015 → Dec 22, 2016
NCT ID
NCT02549417About KHK7580
KHK7580 is a phase 3 stage product being developed by Kyowa Kirin for Secondary Hyperparathyroidism. The current trial status is completed. This product is registered under clinical trial identifier NCT02549417. Target conditions include Secondary Hyperparathyroidism.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03280264 | Phase 3 | Completed |
| NCT02549417 | Phase 3 | Completed |
| NCT02549404 | Phase 3 | Completed |
| NCT02143271 | Phase 1 | Completed |
| NCT01935856 | Phase 1/2 | Completed |
Competing Products
20 competing products in Secondary Hyperparathyroidism